Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
Search
Quick response in fighting Foot-and-Mouth-Disease
Colleagues from the Veterinary Public Health helped to contain an outbreak of Foot-and-Mouth Disease (FMD) on the island of Rodrigues in just six days.
World Patient Safety Day 2021
As a sign of support for World Patient Safety Day, Boehringer Ingelheim lights up buildings in orange. Click here to learn and find out more.
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”. Find out more here.
Poultry Innovation Days 2018
As a global leader in poultry disease prevention, Boehringer Ingelheim gathered more than 500 leaders in the global poultry industry in Prague. Learn more.
New approaches in the battle against heartworm disease
Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. Read more.
Patient documentary - From diagnosis to everyday living
Hear these four brave people share personal experiences of the impact being diagnosed with type 2 diabetes and heart disease has had on them, and more.
Heart Diseases
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
Marek's Disease Poultry Chicken
Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems. Learn more here.
Transboundary and emerging diseases
We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks.
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
Chronic Kidney Disease
Chronic kidney disease affects approximately 850 million people worldwide which is more than ten percent of the population.
World Water Day: Good Health Hinges on Good Water
Water availability and quality affects many aspects of individual, societal and environmental health. Good health hinges on good water. Learn more here.
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach is a herculean task – but also an innovation that carries huge potential. Learn more here.
Metabolic Diseases
Interconnected cardio-renal-metabolic conditions – affecting the heart, kidneys, and metabolic system – are the leading cause of mortality worldwide.
CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults
CDSCO approves SPEVIGO® (spesolimab)
Practical Advice
In this short documentary, we hear from Dr Hull, who is involved in the treatment of people with type 2 diabetes and heart disease. Find out more.
COVID-19 Volunteering in a Food Bank to help the new poors
Massimo Grasso volunteered 10 days in a national organisation in Italy supporting charities working for food distribution to families in need.
Introducing Karl and Klara Kidney
Kidney disease and type 2 diabetes are closely linked, and share many of the same risk factors and pathological pathways. Click here to find out more.
fighting pet parasites with holistic approach france
When animals are healthy, humans are healthier, too. This is especially true for parasitic diseases that affect our pets to whom we are close. Read more.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Patient Voices...Ian's Story
Watch the video to find out more about how Ian manages AF in his day to day life. Ian discusses the importance of educating yourself and more.
Podcast: Journeys through pulmonary fibrosis
As we speak to the courageous pulmonary fibrosis community, we hear heart-warming stories of determination, resilience and spirit. Click here to listen.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.